Medicare Enrolled
Dr. Sanjay Kunapuli, MD
Interventional Cardiology · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kunapuli from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kunapuli? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kunapuli
Dr. Sanjay Kunapuli is an interventional cardiology in Houston, TX, with 18 years in practice. Based on federal Medicare data, Dr. Kunapuli performed 4,552 Medicare services across 3,341 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kunapuli received a total of $309,823 from 59 pharmaceutical and/or device companies across 835 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kunapuli is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice▲ Top 16% volume in TX$ $309,823 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,552
Medicare services
Top 16% in TX for interventional cardiology
3,341
Unique beneficiaries
$93
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~253 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report | 621 | $6 | $50 |
| Office visit, established patient (30-39 min) | 583 | $91 | $314 |
| Regadenoson injection (Lexiscan) for heart stress test | 500 | $44 | $212 |
| Echocardiogram, transthoracic | 393 | $143 | $1,461 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 280 | $21 | $120 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 259 | $25 | $35 |
| Electrocardiogram (EKG), 12-lead | 242 | $10 | $126 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 137 | $352 | $3,509 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 136 | $50 | $406 |
| Evaluation of cardiac rhythm monitor system | 128 | $38 | $168 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 126 | $10 | $64 |
| Initial hospital admission, high complexity | 110 | $135 | $588 |
| Office visit, established patient (20-29 min) | 94 | $70 | $212 |
| New patient office visit, complex (60-74 min) | 86 | $160 | $600 |
| Cardiac catheterization | 58 | $182 | $1,310 |
| Insertion of tube into artery of lobe of lung | 48 | $68 | $932 |
| Drug infusion during cardiac catheterization | 45 | $77 | $442 |
| Insertion of tube into vein, first order branch | 42 | $64 | $833 |
| Hospital follow-up visit, high complexity | 42 | $92 | $302 |
| Office visit, established patient, complex (40-54 min) | 40 | $120 | $421 |
| Insertion of tube into vena cava | 35 | $42 | $772 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 35 | $41 | $175 |
| Insertion of tube into vein, second order branch | 32 | $72 | $1,116 |
| Review by radiologist of major lower body vein image | 31 | $41 | $209 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 31 | $74 | $403 |
| Coronary stent placement | 30 | $466 | $2,405 |
| Ultrasound of heart with probe in esophagus, with report | 27 | $85 | $503 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 26 | $2 | $252 |
| New patient office visit (45-59 min) | 26 | $129 | $483 |
| Insertion of heart rhythm monitor under skin | 25 | $3,509 | $26,634 |
| Insertion of tube into left or right pulmonary artery | 24 | $61 | $807 |
| Primary removal and dissolving of blood clot from artery or artery graft using fluoroscopic guidance, subsequent vessels | 22 | $131 | $1,034 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 22 | $235 | $1,642 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 21 | $146 | $1,028 |
| Review by radiologist of both arms and legs veins of both arms or legs image | 19 | $52 | $193 |
| Insertion of vena cava filter with review by radiologist | 16 | $98 | $1,204 |
| Insertion of tube into chest or arm artery, initial second order branch | 15 | $116 | $1,416 |
| Review by radiologist of 1 arm or leg vein of 1 arm or leg image | 15 | $38 | $130 |
| Ultrasound of heart, follow-up | 15 | $69 | $451 |
| Removal and dissolving of blood clot from vein using fluoroscopic guidance, initial treatment | 14 | $281 | $2,607 |
| External shock to heart to regulate heart beat | 14 | $87 | $540 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, each additional vessel | 14 | $61 | $309 |
| Insertion of tube into right heart or main pulmonary artery | 13 | $50 | $679 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 13 | $52 | $268 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 13 | $6 | $34 |
| Insertion of tube into chest or arm artery, each first order branch | 12 | $85 | $1,255 |
| Primary removal and dissolving of blood clot from artery or artery graft using fluoroscopic guidance, initial vessel | 11 | $346 | $2,807 |
| Ultrasound of both sides of head and neck blood flow | 11 | $150 | $1,003 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
13.5% high complexity
19.6% medium
66.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$309,823
Total received (2018-2024)
Avg $44,260/year across 7 years
Top 2% in TX for interventional cardiology
59
Companies
835
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$272,481 (87.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,285 (7.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$15,057 (4.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$21,507
2023$35,987
2022$54,550
2021$19,502
2020$33,648
2019$86,058
2018$58,571
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$204,857
Inari Medical, Inc.
$44,234
Esperion Therapeutics, Inc.
$25,160
Abbott Laboratories
$23,579
Penumbra, Inc.
$2,338
Boston Scientific Corporation
$1,250
Amgen Inc.
$760
Cardiovascular Systems Inc.
$753
Novartis Pharmaceuticals Corporation
$684
ABIOMED
$518
Medtronic Vascular, Inc.
$482
Biosense Webster, Inc.
$338
Actelion Pharmaceuticals US, Inc.
$302
BIOTRONIK INC.
$290
E.R. Squibb & Sons, L.L.C.
$265
Medtronic, Inc.
$264
Merck Sharp & Dohme LLC
$259
PFIZER INC.
$227
Impulse Dynamics (USA) Inc.
$218
Baxter Healthcare
$216
HeartFlow, Inc.
$185
iRhythm Technologies, Inc.
$183
HEARTFLOW, INC.
$164
Amarin Pharma Inc.
$162
Janssen Scientific Affairs, LLC
$160
BARD PERIPHERAL VASCULAR, INC.
$157
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$157
Boehringer Ingelheim Pharmaceuticals, Inc.
$137
Tactile Systems Technology Inc
$129
Cardinal Health 200, LLC
$119
BOSTON SCIENTIFIC CORPORATION
$112
Bard Peripheral Vascular, Inc.
$106
ATRICURE, INC.
$98
Lexicon Pharmaceuticals, Inc.
$81
Cook Medical LLC
$78
Novo Nordisk Inc
$76
CARDIVA MEDICAL, INC.
$63
Itamar Medical Inc
$55
Gilead Sciences, Inc.
$51
SANOFI-AVENTIS U.S. LLC
$51
Chiesi USA, Inc.
$51
GE HEALTHCARE
$49
AltaThera Pharmaceuticals LLC
$42
AstraZeneca Pharmaceuticals LP
$41
Merck Sharp & Dohme Corporation
$39
Kiniksa Pharmaceuticals, Ltd.
$38
Regeneron Healthcare Solutions, Inc.
$38
AngioDynamics, Inc.
$29
Lundbeck LLC
$22
SCPHARMACEUTICALS INC.
$22
Azurity Pharmaceuticals, Inc.
$19
Aziyo Biologics, Inc.
$19
ARBOR PHARMACEUTICALS, INC.
$17
Teleflex LLC
$17
Preventice Services, LLC
$16
Dilon Technologies, Inc.
$13
Kowa Pharmaceuticals America, Inc.
$13
ConvaTec Inc.
$12
Allergan Inc.
$11
Top 3 companies account for 88.5% of total payments
Associated products mentioned in payments ›
ADROIT Guiding Catheter · ADVANCE · ALPHAVAC · AMPLATZER AMULET · ANGIOJET · AQUACEL AG+ EXTRA · ATRICLIP LAA EXCLUSION SYSTEM · Accent Pacemaker · Advance · Arcalyst · Assurity Pacemaker · BIOMONITOR · BYSTOLIC · BodyGuardian · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE 6/7F VCS · CARTO 3 · CHANTIX · COBALT DR MRI SURESCAN · CONFIRM RX · COOK CELECT · CRT Leads · CT THROMBECTOMY SYSTEM KIT · Cardiac Mapping System · CardioMEMS HF System · Circulatory Support · ClosureRFS · Confirm Rx · Connectivity and Remote care · CoreValve Evolut · Corlanor · DRAGONFLY OPSTAR · Durata Defibrillation ICD Lead · ECM · EDARBI · ELIQUIS · ENSITE · ENSITE PRECISION · ENTRESTO · Edarbi · EnSite Precision Cardiac Mapping System · Ensite Cardiac Mapping System · Epic Stented Tissue Valve · FARXIGA · FFRct · FLOWTRIEVER CATHETER · FUROSCIX · Flexitouch Plus · GALLANT · Hillrom - Cardiac Ambulatory Monitor · Hillrom - Carnation Ambulatory Monitor · ICDs · Impella · Indigo System · Inpefa · JARDIANCE · JOT DX · KENGREAL · LEQVIO · LIFESTENT · LINQ II · LUTONIX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MERLIN@HOME · MULTAQ · Merlin Connectivity and Remote · NEXLETOL · NEXLIZET · NORTHERA · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · Optimizer · Ozempic · PRALUENT · PRESSUREWIRE · Pacemakers · Peripheral Orbital Atherectomy System · RESONATE EL ICD VR · ROTABLATOR · Repatha · Resolute · Reveal LINQ · Rivacor · S · SEEQ · SELECTSITE · SYNERGY · Sotalol Hydrochloride · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · TRAPLINER · TRUEVIEW · ULTRASCORE · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WOLVERINE · WatchPAT · WatchPATONE · XARELTO · XIENCE V · ZILVER PTX · ZIO XT Patch · Zio monitor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (88%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in interventional cardiology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for interventional cardiology in TX.
Equivalent to $6,806 per 100 Medicare services performed
Geographic Context
Interventional Cardiologys within 10 mi
65
Per 100K population
1.4
County median income
$73,104
Nearest hospital
HOUSTON METHODIST WILLOWBROOK HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kunapuli is a clinical cardiology specialist, with above-average Medicare volume (top 16% in TX), and high industry engagement (speaking/promotional, top 2%), with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kunapuli experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Kunapuli performed 621 ekg interpretation and report services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kunapuli receive payments from pharmaceutical companies?
Yes. Dr. Kunapuli received a total of $309,823 from 59 companies across 835 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kunapuli's costs compare to other interventional cardiologys in Houston?
Dr. Kunapuli's average Medicare payment per service is $93. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kunapuli) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Cardiologys in Houston
Browse interventional cardiologys in Houston ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologys in TX
Interventional Cardiologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologys in TX
Which TX interventional cardiologys receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Inari Medical, Inc. Payments to Doctors
See all physicians who received payments from Inari Medical, Inc..
By company
Esperion Therapeutics, Inc. Payments to Doctors
See all physicians who received payments from Esperion Therapeutics, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology